Literature DB >> 21564163

Naloxone decreases the inhibitory effect of alprazolam on the release of adrenocorticotropin/cortisol induced by physical exercise in man.

Vittorio Coiro1, Riccardo Volpi, Amos Casti, Maria Ludovica Maffei, Adriano Stella, Elio Volta, Paolo Chiodera.   

Abstract

WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT:Alprazolam (ALP), a benzodiazepine activating GABAergic receptors, is involved in ACTH secretion. WHAT THIS STUDY ADDS: • This study demonstrates a partial opioid influence in the inhibitory effect of ALP on the release of ACTH/cortisol during physical exercise. AIMS: To establish the possible involvement of alprazolam (ALP) and/or opiates in the mechanism underlying the ACTH/cortisol response to physical exercise.
METHODS: Tests were carried out under basal conditions (exercise control test), exercise plus ALP (50 µg at time -90 min), naloxone (10 mg at time 0) or ALP plus naloxone. Plasma ACTH and serum cortisol concentrations were evaluated in blood samples taken before, during and after the bicycle ergometer tests.
RESULTS: ACTH and cortisol concentrations rose significantly after physical exercise. Maximum peak at time 15 min (P ≤ 0.01 vs. baseline) for ACTH and at time 30 min (P ≤ 0.01 vs. baseline) for cortisol. In the presence of naloxone, the ACTH and cortisol responses were significantly increased (maximum peak at time 20 min, P ≤ 0.02 vs. control test for ACTH, and at time 30 min (P ≤ 0.01 vs. baseline) for cortisol) whereas they were abolished by ALP. When ALP and naloxone were given together, the inhibitory effect of ALP was partial.
CONCLUSIONS: These data demonstrate an inhibitory effect of ALP in the regulation of the ACTH/cortisol response to physical exercise in man and suggest that GABAergic receptor activating benzodiazepines and opioids interact in the neuroendocrine secretion of ACTH/cortisol.
© 2011 The Authors. British Journal of Clinical Pharmacology © 2011 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21564163      PMCID: PMC3099383          DOI: 10.1111/j.1365-2125.2010.03900.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  14 in total

1.  On the site of action of naloxone-stimulated cortisol secretion in gilts.

Authors:  M J Estienne; J S Kesner; C R Barb; R R Kraeling; G B Rampacek
Journal:  Life Sci       Date:  1988       Impact factor: 5.037

2.  Effects of dehydroepiandrosterone and alprazolam on hypothalamic-pituitary responses to exercise.

Authors:  Patricia A Deuster; Martha M Faraday; George P Chrousos; Merrily A Poth
Journal:  J Clin Endocrinol Metab       Date:  2005-05-31       Impact factor: 5.958

3.  In vitro and in vivo effects of the triazolobenzodiazepine alprazolam on hypothalamic-pituitary-adrenal function: pharmacological and clinical implications.

Authors:  K T Kalogeras; A E Calogero; T Kuribayiashi; I Khan; W T Gallucci; M A Kling; G P Chrousos; P W Gold
Journal:  J Clin Endocrinol Metab       Date:  1990-05       Impact factor: 5.958

4.  Localization of immunoreactive enkephalins in GABA synthesizing neurons of the rat neostriatum.

Authors:  N Aronin; M Difiglia; G A Graveland; W J Schwartz; J Y Wu
Journal:  Brain Res       Date:  1984-05-23       Impact factor: 3.252

5.  Alprazolam (a benzodiazepine activating GABA receptor) reduces the neuroendocrine responses to insulin-induced hypoglycaemia in humans.

Authors:  Roberta Giordano; Silvia Grottoli; PierClaudio Brossa; Micaela Pellegrino; Silvia Destefanis; Fabio Lanfranco; Laura Gianotti; Ezio Ghigo; Emanuela Arvat
Journal:  Clin Endocrinol (Oxf)       Date:  2003-09       Impact factor: 3.478

6.  Effects of alprazolam on pituitary-adrenal and catecholaminergic responses to metabolic stress in humans.

Authors:  A Breier; O Davis; R Buchanan; S J Listwak; C Holmes; D Pickar; D S Goldstein
Journal:  Biol Psychiatry       Date:  1992-11-15       Impact factor: 13.382

7.  The stress-, but not corticotropin-releasing hormone-induced activation of the pituitary-adrenal axis in man is blocked by alprazolam.

Authors:  T Rohrer; V von Richthofen; C Schulz; J Beyer; H Lehnert
Journal:  Horm Metab Res       Date:  1994-04       Impact factor: 2.936

8.  Alprazolam blocks the naloxone-stimulated hypothalamo-pituitary-adrenal axis in man.

Authors:  D J Torpy; J E Grice; G I Hockings; M M Walters; G V Crosbie; R V Jackson
Journal:  J Clin Endocrinol Metab       Date:  1993-02       Impact factor: 5.958

Review 9.  Endogenous opioid peptides and hypothalamic neuroendocrine neurones.

Authors:  R J Bicknell
Journal:  J Endocrinol       Date:  1985-12       Impact factor: 4.286

10.  Effect of naloxone on somatostatin inhibition of arginine vasopressin response to physical exercise in normal men.

Authors:  V Coiro; A Casti; P Rubino; G Manfredi; M L Maffei; E Volta; S Cataldo; A Melani; G Saccani Jotti; P Chiodera
Journal:  J Neural Transm (Vienna)       Date:  2008-02-08       Impact factor: 3.575

View more
  3 in total

1.  Stereotypic head twirls, but not pacing, are related to a 'pessimistic'-like judgment bias among captive tufted capuchins (Cebus apella).

Authors:  Ori Pomerantz; Joseph Terkel; Stephen J Suomi; Annika Paukner
Journal:  Anim Cogn       Date:  2012-04-20       Impact factor: 3.084

2.  Effects of Antecedent GABA A Receptor Activation on Counterregulatory Responses to Exercise in Healthy Man.

Authors:  Maka S Hedrington; Donna B Tate; Lisa M Younk; Stephen N Davis
Journal:  Diabetes       Date:  2015-04-21       Impact factor: 9.461

3.  Effects of γ-Aminobutyric Acid A Receptor Activation on Counterregulatory Responses to Subsequent Exercise in Individuals With Type 1 Diabetes.

Authors:  Maka S Hedrington; Maia Mikeladze; Donna B Tate; Lisa M Younk; Ian Davis; Stephen N Davis
Journal:  Diabetes       Date:  2016-05-23       Impact factor: 9.461

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.